Annual Debt To Equity
0.00
-0.01-100.00%
March 31, 2024
Summary
- As of February 20, 2025, ACST annual debt to equity ratio is 0.00, with the most recent change of -0.01 (-100.00%) on March 31, 2024.
- During the last 3 years, ACST annual debt to equity has risen by 0.00 (0.00%).
Performance
ACST Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Debt To Equity
N/A
September 30, 2024
Summary
- ACST quarterly debt to equity ratio is not available.
Performance
ACST Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
ACST Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | - |
| 3 y3 years | 0.0% | - |
| 5 y5 years | -100.0% | - |
ACST Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | ||
| 5 y | 5-year | -100.0% | at low | ||
| alltime | all time | -100.0% | at low |
Acasti Pharma Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | 0.00(0.0%) |
| Mar 2024 | 0.00(-100.0%) | 0.00(0.0%) |
| Dec 2023 | - | 0.00(0.0%) |
| Sep 2023 | - | 0.00(0.0%) |
| Jun 2023 | - | 0.00(-100.0%) |
| Mar 2023 | 0.01(>+9900.0%) | 0.01(0.0%) |
| Dec 2022 | - | 0.01(0.0%) |
| Sep 2022 | - | 0.01(0.0%) |
| Jun 2022 | - | 0.01(>+9900.0%) |
| Mar 2022 | 0.00(0.0%) | 0.00(0.0%) |
| Dec 2021 | - | 0.00(0.0%) |
| Sep 2021 | - | 0.00(0.0%) |
| Jun 2021 | - | 0.00(0.0%) |
| Mar 2021 | 0.00(0.0%) | 0.00(0.0%) |
| Dec 2020 | - | 0.00(0.0%) |
| Sep 2020 | - | 0.00(0.0%) |
| Jun 2020 | - | 0.00(0.0%) |
| Mar 2020 | 0.00(-100.0%) | 0.00(-100.0%) |
| Dec 2019 | - | -0.32(-72.2%) |
| Sep 2019 | - | -1.15(-321.2%) |
| Jun 2019 | - | 0.52(+333.3%) |
| Mar 2019 | 0.12(-40.0%) | 0.12(+100.0%) |
| Dec 2018 | - | 0.06(-150.0%) |
| Sep 2018 | - | -0.12(-154.5%) |
| Jun 2018 | - | 0.22(+10.0%) |
| Mar 2018 | 0.20(+233.3%) | 0.20(+100.0%) |
| Dec 2017 | - | 0.10(0.0%) |
| Sep 2017 | - | 0.10(+25.0%) |
| Jun 2017 | - | 0.08 |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | 0.06(>+9900.0%) | - |
| Nov 2016 | - | 0.00(0.0%) |
| Aug 2016 | - | 0.00(0.0%) |
| May 2016 | - | 0.00(0.0%) |
| Feb 2016 | 0.00(0.0%) | 0.00(0.0%) |
| Nov 2015 | - | 0.00(0.0%) |
| Aug 2015 | - | 0.00(0.0%) |
| May 2015 | - | 0.00(0.0%) |
| Feb 2015 | 0.00(0.0%) | 0.00(0.0%) |
| Nov 2014 | - | 0.00(0.0%) |
| Aug 2014 | - | 0.00(0.0%) |
| May 2014 | - | 0.00(0.0%) |
| Feb 2014 | 0.00(0.0%) | 0.00(0.0%) |
| Nov 2013 | - | 0.00(0.0%) |
| Aug 2013 | - | 0.00(0.0%) |
| May 2013 | - | 0.00(0.0%) |
| Feb 2013 | 0.00(0.0%) | 0.00(0.0%) |
| Nov 2012 | - | 0.00(0.0%) |
| Aug 2012 | - | 0.00(0.0%) |
| May 2012 | - | 0.00(0.0%) |
| Feb 2012 | 0.00(0.0%) | 0.00(0.0%) |
| Nov 2011 | - | 0.00(0.0%) |
| Aug 2011 | - | 0.00(0.0%) |
| May 2011 | - | 0.00(0.0%) |
| Feb 2011 | 0.00(0.0%) | 0.00(0.0%) |
| Nov 2010 | - | 0.00(0.0%) |
| Aug 2010 | - | 0.00(0.0%) |
| May 2010 | - | 0.00(0.0%) |
| Feb 2010 | 0.00 | 0.00(0.0%) |
| Nov 2009 | - | 0.00 |
FAQ
- What is Acasti Pharma annual debt to equity ratio?
- What is the all time high annual debt to equity for Acasti Pharma?
- What is Acasti Pharma annual debt to equity year-on-year change?
- What is the all time high quarterly debt to equity for Acasti Pharma?
What is Acasti Pharma annual debt to equity ratio?
The current annual debt to equity of ACST is 0.00
What is the all time high annual debt to equity for Acasti Pharma?
Acasti Pharma all-time high annual debt to equity ratio is 0.20
What is Acasti Pharma annual debt to equity year-on-year change?
Over the past year, ACST annual debt to equity ratio has changed by -0.01 (-100.00%)
What is the all time high quarterly debt to equity for Acasti Pharma?
Acasti Pharma all-time high quarterly debt to equity ratio is 0.52